Population Health

The UM-IHC Population Health Research Program, directed by Rozalina G. McCoy, MD MS, is an interdisciplinary research program focused on improving the health and well-being of the people of Maryland as well as communities around the U.S. and the world.  

 

 

The Population Health Program is grounded in epidemiological, health services, data science, and biostatistics research methods aimed at: (1) Elucidating the clinical and structural drivers of health and disease; (2) Improving the quality of health care through population health interventions and research; (3) Collaborating with UMMS to evaluate the impact of care delivery interventions on its population of patients with regard to health outcomes, patient experience, access to care, cost of care, and practice efficiencies; (4) Collaborating with other areas of discovery within the UM-IHC to support the population health focus of research being conducted within the Institute; and (5) Partnering with patients and patient advocacy groups, public health agencies, and community organizations to inform and evaluate community-based interventions that improve population health.

Research conducted within the Population Health Program, therefore, aims to identify gaps, challenges, and opportunities to improve population health; to identify optimal care strategies to improve population health; and ensure equitable and sustainable translation of research findings to narrow and ultimately eliminate health disparities. 

The UM-IHC Population Health Program supports a large portfolio of research in several key areas: 

Rozalina G. McCoy, MD, MS
Director of Precision Medicine and Population Health

Mohan Suntha headshot

“As a health care leader serving diverse communities across the state, the University of Maryland Medical System is proud to be a founding partner institution. De-identified data from patients across our System, paired with clinical research data from our partners at UMB, will provide the data backbone for advanced analytics that will help deliver faster diagnoses and improvements in how therapeutics are utilized while helping develop the cures of tomorrow.”

Mohan Suntha, President and CEO of the University of Maryland Medical System